EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SRRM2 splicing factor modulates cell fate in early development

Silvia Carvalho iD, Luna Zea-Redondo iD, Tsz Ching Chloe Tang iD, Philipp Stachel-Braum iD, Duncan Miller iD, Paulo Caldas iD, Alexander Kukalev iD, Sebastian Diecke iD, Stefanie Grosswendt iD, Ana Rita Grosso iD, Ana Pombo iD

Biology Open · 2024

DOI: 10.1242/bio.060415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology Open, 2024. Verfasst von Silvia Carvalho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Epigenetic Regul…. Hauptthemen laut MEDLINE: Cell Differentiation, Embryonic Development, Gene Expression Regulation, Developmental. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Deutsche Forschungsgemeinschaft, HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Embryo development is an orchestrated process that relies on tight regulation of gene expression to guide cell differentiation and fate decisions. The Srrm2 splicing factor has recently been implicated in developmental disorders and diseases, but its role in early mammalian development remains unexplored. Here, we show that Srrm2 dosage is critical for maintaining embryonic stem cell pluripotency and cell identity. Srrm2 heterozygosity promotes loss of stemness, characterised by the coexistence of cells expressing naive and formative pluripotency markers, together with extensive changes in gene expression, including genes regulated by serum-response transcription factor (SRF) and differentiation-related genes. Depletion of Srrm2 by RNA interference in embryonic stem cells shows that the earliest effects of Srrm2 heterozygosity are specific alternative splicing events on a small number of genes, followed by expression changes in metabolism and differentiation-related genes. Our findings unveil molecular and cellular roles of Srrm2 in stemness and lineage commitment, shedding light on the roles of splicing regulators in early embryogenesis, developmental diseases and tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationEmbryonic DevelopmentGene Expression Regulation, DevelopmentalAnimalsMiceAlternative SplicingEmbryonic Stem CellsRNA-Binding ProteinsHumans

Stichwörter der Autor:innen

PluripotencySRm300Single-cell transcriptomicsSplicingSrrm2Stemness

Substanzen

RNA-Binding Proteins

Autor:innen und Institutionen

  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Epigenetic Regulation and Chromatin Structure Group, 10115 Berlin, Germany.
  • Associate Laboratory i4HB - Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.
  • UCIBIO - Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.
  • Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, 4050-313 Porto, Portugal.
  • Graduate Program in Areas of Basic and Applied Biology (GABBA), ICBAS, University of Porto, 4050-313 Porto, Portugal.
  • Humboldt-Universität zu Berlin, Institute of Biology, 10115 Berlin, Germany.

ORCID-Profile: Silvia Carvalho, Luna Zea-Redondo, Tsz Ching Chloe Tang, Philipp Stachel-Braum, Duncan Miller, Paulo Caldas, Alexander Kukalev, Sebastian Diecke, Stefanie Grosswendt, Ana Rita Grosso, Ana Pombo

Förderung

  • Fundação para a Ciência e Tecnologia
  • Deutsche Forschungsgemeinschaft
  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • Helmholtz Association

Zitieren

APA

Carvalho, S., Zea-Redondo, L., Tang, T. C. C., Stachel-Braum, P., Miller, D., Caldas, P., Kukalev, A., Diecke, S., Grosswendt, S., Grosso, A. R., & Pombo, A. (2024). SRRM2 splicing factor modulates cell fate in early development. Biology Open. https://doi.org/10.1242/bio.060415

Vancouver

Carvalho S, Zea-Redondo L, Tang TCC, Stachel-Braum P, Miller D, Caldas P, et al. SRRM2 splicing factor modulates cell fate in early development. Biology Open. 2024. doi:10.1242/bio.060415

BibTeX
@article{Carvalho2024,
  author = {Carvalho, Silvia and Zea-Redondo, Luna and Tang, Tsz Ching Chloe and Stachel-Braum, Philipp and Miller, Duncan and Caldas, Paulo and Kukalev, Alexander and Diecke, Sebastian and Grosswendt, Stefanie and Grosso, Ana Rita and Pombo, Ana},
  title = {SRRM2 splicing factor modulates cell fate in early development},
  journal = {Biology Open},
  year = {2024},
  doi = {10.1242/bio.060415}
}
Kostenlos starten →